ChromaDex Corp (CDXC)
3.55
-0.01
(-0.28%)
USD |
NASDAQ |
Apr 30, 16:00
3.51
-0.04
(-1.13%)
After-Hours: 20:00
ChromaDex Price to Book Value: 9.289 for April 30, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 29, 2024 | 9.422 |
April 26, 2024 | 9.104 |
April 25, 2024 | 8.972 |
April 24, 2024 | 8.998 |
April 23, 2024 | 8.998 |
April 22, 2024 | 7.807 |
April 19, 2024 | 9.766 |
April 18, 2024 | 10.03 |
April 17, 2024 | 10.51 |
April 16, 2024 | 10.43 |
April 15, 2024 | 10.40 |
April 12, 2024 | 10.19 |
April 11, 2024 | 10.82 |
April 10, 2024 | 10.37 |
April 09, 2024 | 10.53 |
April 08, 2024 | 11.14 |
April 05, 2024 | 10.64 |
April 04, 2024 | 11.43 |
April 03, 2024 | 10.45 |
April 02, 2024 | 9.501 |
April 01, 2024 | 9.554 |
March 28, 2024 | 9.210 |
March 27, 2024 | 9.713 |
March 26, 2024 | 10.16 |
March 25, 2024 | 10.03 |
Date | Value |
---|---|
March 22, 2024 | 9.422 |
March 21, 2024 | 8.469 |
March 20, 2024 | 8.098 |
March 19, 2024 | 7.172 |
March 18, 2024 | 7.913 |
March 15, 2024 | 6.352 |
March 14, 2024 | 5.425 |
March 13, 2024 | 5.558 |
March 12, 2024 | 5.161 |
March 11, 2024 | 4.631 |
March 08, 2024 | 4.552 |
March 07, 2024 | 4.234 |
March 06, 2024 | 4.605 |
March 05, 2024 | 4.578 |
March 04, 2024 | 4.393 |
March 01, 2024 | 4.242 |
February 29, 2024 | 4.400 |
February 28, 2024 | 4.532 |
February 27, 2024 | 4.558 |
February 26, 2024 | 4.348 |
February 23, 2024 | 4.005 |
February 22, 2024 | 4.005 |
February 21, 2024 | 4.005 |
February 20, 2024 | 4.190 |
February 16, 2024 | 4.269 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.500
Minimum
Apr 27 2023
75.56
Maximum
Feb 25 2021
10.17
Average
8.515
Median
Dec 06 2021
Price to Book Value Benchmarks
Talphera Inc | 1.239 |
Viemed Healthcare Inc | 2.787 |
Perspective Therapeutics Inc | 13.23 |
Electromed Inc | 3.684 |
Xtant Medical Holdings Inc | 2.257 |
Price to Book Value Related Metrics
PS Ratio | 3.149 |
Price to Free Cash Flow | 37.77 |
Price | 3.55 |
Earnings Yield | -1.99% |
Market Cap | 267.35M |